Hers vs Telos Rx: Brand-name Wegovy vs Compounded GLP-1 Options
Choosing between Hers and Telos Rx comes down to whether you prefer FDA-approved brand-name medication or lower-cost compounded GLP-1 options. Early verdict: Hers provides FDA-approved Wegovy® (brand-name semaglutide) starting at $149/mo with a membership requirement, while Telos Rx offers compounded semaglutide and tirzepatide as low as $99/mo and $139/mo respectively, with compounded medications not FDA-approved and subject to review by a US-licensed provider.
Hers vs Telos Rx: Key differences at a glance
The comparison below focuses on the most distinctive differences supported by the sources: regulatory status of medications, pricing and membership, medication options, clinical review and availability, and claims about outcomes. Each item preserves the exact qualifiers provided.
1. Regulatory status: FDA-approved brand-name vs compounded products
Hers emphasizes FDA-approved Wegovy® (brand-name semaglutide) and states no compounded medications are offered. The source repeatedly notes Wegovy® is FDA-approved and not a compounded product. Telos Rx offers compounded semaglutide and tirzepatide and explicitly states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. These are direct, contrasted claims from each provider.
See Telos Rx pricing and options
2. Pricing and membership requirements
Hers lists Wegovy® from $149/mo and notes that an active Hers Weight Loss Membership is required, with a $39 first month and auto-renews at $149/month thereafter; it states medication is not available without an active membership and that total cost includes membership and medication billed separately. Telos Rx lists semaglutide as low as $99 per month and tirzepatide as low as $139 per month, and says you may “Pay $0 if not approved” and “Cancel anytime, no penalties.” Telos Rx also notes your price depends on your plan.
Compare Hers membership details
3. Medication choices and dosing distinctions
Hers highlights FDA-approved Wegovy® and mentions semaglutide and tirzepatide offerings with price points listed (examples include semaglutide from $149/mo and tirzepatide from $299/mo in parts of the source). Hers emphasizes name brand medication and “no price markups.” Telos Rx offers compounded semaglutide and tirzepatide and describes tirzepatide as acting on GLP-1 plus GIP while semaglutide acts on GLP-1. Telos Rx states a US-licensed provider decides which molecule is right for you.
4. Clinical review, approvals and availability
Both providers state treatment is available only when a licensed clinician determines it is medically appropriate. Hers explicitly notes prescription required, not available in all 50 states, and that Ozempic® and Mounjaro® are available only to patients who meet clinical eligibility criteria, as determined by a licensed healthcare provider. Telos Rx states compounded medications are prescription-only and prescribed only after review by a US-licensed provider and that individual results vary and are not guaranteed.
5. Outcome claims and supporting language
Hers includes outcome examples captured on the landing page such as “62 lbs lost in 12 months” and “54 lbs lost in 6 months” but also emphasizes that treatment is available only when clinically appropriate and that compounded medications, when offered, are not FDA-approved. Telos Rx cautions that individual results vary and are not guaranteed and repeats the regulatory note that compounded medications are not FDA-approved.
| Criteria | Hers | Telos Rx |
|---|---|---|
| Medication regulatory status | FDA-approved Wegovy®, not compounded | Compounded semaglutide and tirzepatide; not FDA-approved |
| Starting price | Wegovy® from $149/mo | Semaglutide as low as $99/mo; tirzepatide as low as $139/mo |
| Membership required | Active Hers Membership required ($39 first month, auto-renews $149/mo) | Cancel anytime, no penalties; pay $0 if not approved |
| Clinical review | Treatment only when licensed clinician determines medically appropriate; prescription required | Prescribed only after review by a US-licensed provider; subject to approval |
| Availability note | Not available in all 50 states; prescription required | State coverage and pricing may change; prescription-only |
How to decide between Hers and Telos Rx
If having FDA-approved, brand-name Wegovy® matters and you accept a required membership and its billing terms, Hers is the option that explicitly offers brand-name Wegovy® and states no compounded medications are provided. If lower out-of-pocket price and access to compounded semaglutide or tirzepatide are your priority, Telos Rx lists semaglutide as low as $99/mo and tirzepatide as low as $139/mo, with prescriptions and pricing subject to approval by a US-licensed provider. Remember that Telos Rx states compounded medications are not FDA-approved.
Review Telos Rx enrollment steps
Get Hers enrollment and pricing
Final recommendation: Hers vs Telos Rx
Hers vs Telos Rx boils down to FDA-approved brand medication with membership obligations versus lower-cost compounded options subject to clinical approval and not FDA-reviewed. Choose Hers if you prioritize FDA-approved Wegovy® and a personalized care team with dose check-ins and accept the membership requirement. Choose Telos Rx if you prioritize lower starting monthly price and are willing to use compounded semaglutide or tirzepatide with prescriptions issued after review by a US-licensed provider.